Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • k-gun12
    Member
    • Feb 2010
    • 56

    Alternative to CLC Genomics Workbench viewer

    Qiagen has hiked the pricing and changed the licensing terms of the CLC software line to the point that I can no longer afford it after a decade of use. What I found myself using particularly in the later years was the viewer; it was useful for viewing, scrolling and annotating short-read and spliced alignments based on the mapping, piecing together gene structures, finding splice sites, polymorphisms, etc. I've tried IGV but found it a little clunky.. are there any other decent alternatives out there?

    Thanks!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Sounds like you are/were a power CLC user. When you have used a program for a decade anything else you try is going to feel ... different. Following examples are more or less pure viewers.

    IGB (http://bioviz.org/igb/), Tablet (https://ics.hutton.ac.uk/tablet/) are a couple of other options. Golden helix (an otherwise commercial software) has a genome browser available for free (http://goldenhelix.com/products/GenomeBrowse/index.html).

    Comment

    • k-gun12
      Member
      • Feb 2010
      • 56

      #3
      Thanks. I'll check those out. I don't mind going commercial again, but the way Qiagen treated existing CLC customers as a cash cow after buying the company was pretty bad.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Look into Geneious , if you are ok going commercial.

        Comment

        • gringer
          David Eccles (gringer)
          • May 2011
          • 845

          #5
          Originally posted by k-gun12 View Post
          the way Qiagen treated existing CLC customers as a cash cow after buying the company was pretty bad.
          My probably-biased point of view (as a bioinformatician) is that even with the original CLC prices, a company would get more benefit out of hiring a dedicated bioinformatician than paying for CLC.

          Someone needs to interpret the results produced by CLC, and the skill/training gap between result interpretation and result generation from [much] cheaper software is quite small. If a bit of hand-holding is needed, I'd recommend Geneious because it has a much more open community and plugin system.

          Comment

          Latest Articles

          Collapse

          • mylaser
            Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by mylaser
            Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
            If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
            This guide explains everything you need to know about...
            Today, 01:13 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          17 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          10 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-02-2026, 11:08 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Working...